Inspire Veterinary Partners, Inc. - Class A Common Stock (IVP)
1.2800
-0.0200 (-1.54%)
NASDAQ · Last Trade: Apr 20th, 4:04 AM EDT
Detailed Quote
Previous Close
1.300
Open
1.260
Bid
1.260
Ask
1.320
Day's Range
1.260 - 1.350
52 Week Range
1.260 - 401.50
Volume
26,463
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
45,551
Chart
About Inspire Veterinary Partners, Inc. - Class A Common Stock (IVP)
Inspire Veterinary Partners, Inc. is a company focused on advancing the veterinary care industry by partnering with and supporting veterinary practices. By providing resources, operational support, and strategic guidance, the company aims to enhance the quality of animal healthcare services. Inspire Veterinary Partners collaborates with a network of veterinary professionals to facilitate growth, efficiency, and innovation within practices, ultimately improving the overall experience for pet owners and their beloved animals. Through these partnerships, the company fosters a commitment to excellence in veterinary medicine, ensuring that practitioners can deliver the highest standard of care. Read More
VIRGINIA BEACH, VA / ACCESS Newswire / April 10, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced its upcoming investor event attendance.
VIRGINIA BEACH, VA / ACCESS Newswire / March 31, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today reported financial results for the full year ended December 31, 2024.
NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / On Mar. 26, 2025, Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., announced it has closed a securities purchase agreement with an investor to purchase 1,092,896 shares of its common stock (or pre-funded warrants in lieu thereof), Series A warrants to purchase 1,092,896 shares of common stock and Series B warrants to purchase 1,092,896 shares of common stock, pursuant to a registered direct offering for aggregate gross proceeds of approximately $2.0 million (the "Offering"). The Series A warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares issuable upon exercise of the warrants (the "Stockholder Approval Date") and will expire five years from the Stockholder Approval Date. The Series B warrants will be exercisable beginning on the Stockholder Approval Date and will expire 18 months from the Stockholder Approval Date. The purchase price for one share of common stock (or pre-funded warrants in lieu thereof) and accompanying two warrants is $1.83. Approximately $2.0 million will be funded in full upon the closing of the Offering, and up to an additional $4.0 million may be funded upon full cash exercise of the warrants. No assurance can be given that any of the warrants will be exercised.
VIRGINIA BEACH, VA / ACCESS Newswire / March 26, 2025 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced it has closed a securities purchase agreement with an investor to purchase 1,092,896 shares of its common stock (or pre-funded warrants in lieu thereof), Series A warrants to purchase 1,092,896 shares of common stock and Series B warrants to purchase 1,092,896 shares of common stock, pursuant to a registered direct offering for aggregate gross proceeds of approximately $2.0 million (the "Offering").The Series A warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares issuable upon exercise of the warrants (the "Stockholder Approval Date") and will expire five years from the Stockholder Approval Date. The Series B warrants will be exercisable beginning on the Stockholder Approval Date and will expire 18 months from the Stockholder Approval Date. The purchase price for one share of common stock (or pre-funded warrants in lieu thereof) and accompanying two warrants is $1.83. Approximately $2.0 million will be funded in full upon the closing of the Offering, and up to an additional $4.0 million may be funded upon full cash exercise of the warrants. No assurance can be given that any of the warrants will be exercised.
VIRGINIA BEACH, VA / ACCESS Newswire / March 25, 2025 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S.,today announced it has entered into a securities purchase agreement with an investor to purchase 1,092,896 shares of its common stock (or a pre-funded warrant in lieu thereof), Series A warrants to purchase 1,092,896 shares of common stock and Series B warrants to purchase 1,092,896 shares of common stock, pursuant to a registered direct offering for aggregate gross proceeds of approximately $2.0 million before deducting fees and other estimated offering expenses (the "Offering").The Series A warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares underlying the warrants (the "Stockholder Approval Date") and will expire five years from the Stockholder Approval Date. The Series B warrants will be exercisable beginning on the Stockholder Approval Date and will expire 18 months from the Stockholder Approval Date. The purchase price for one share of common stock (or pre-funded warrants in lieu thereof) and accompanying two warrants is $1.83. Approximately $2.0 million will be funded in full upon the closing of the Offering, and up to an additional $4.0 million may be funded upon full cash exercise of the warrants. No assurance can be given that any of the warrants will be exercised. The offering is expected to close on or about March 26, 2025, subject to the satisfaction of customary closing conditions.
Proposed acquisition could potentially add approximately $1.8 million (unaudited) revenue, increase Inspire's current locations in Florida to 5, and bring the total number of animal hospitals in its network to 14.
VIRGINIA BEACH, VA / ACCESS Newswire / March 3, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S.,today announced it has engaged STNL Advisors, a full-service net lease advisory firm, to review the Company's real estate portfolio and provide strategic guidance on opportunities to expand, update and add new facilities.
VIRGINIA BEACH, VA / ACCESS Newswire / February 12, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S.,today issued a letter to stockholders from Kimball Carr, the Chief Executive Officer of Inspire.
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
VIRGINIA BEACH, VA / ACCESS Newswire / January 22, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that it will effect a 1-for-25 reverse stock split ("Reverse Stock Split") of its authorized and issued and outstanding shares of Class A common stock, par value $0.0001 per share ("Common Stock"). The Reverse Stock Split will become effective at 12:01am, Eastern Time, on January 27, 2025. At such time, each 25 shares of issued and outstanding Common Stock will automatically be reclassified into one new share of Common Stock. The total number of shares of Common Stock authorized for issuance will then be reduced by a corresponding proportion from 36,998,148 shares to 1,479,926 shares. Proportional adjustments will also be made to outstanding equity awards, warrants and convertible notes, and to the number of shares issued and issuable under the Company's stock incentive plans and certain existing agreements. No fractional shares will be issued in connection with the Reverse Stock Split. All fractional shares will be rounded up. The Reverse Stock Split will affect all common stockholders uniformly and will not alter any stockholder's percentage interest in the Company's equity.
VIRGINIA BEACH, VA / ACCESSWIRE / November 13, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today reported its financial results for the third quarter and nine months ended September 30, 2024.
VIRGINIA BEACH, VA / ACCESSWIRE / October 22, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that it has entered into a securities purchase agreement with institutional investors, providing for the purchase and sale of 10,000,000 million shares of Class A common stock in a registered direct offering, at a price per share of $0.25. The offering is expected to close on or about October 23, 2024, subject to the satisfaction of customary closing conditions.
